Hawal Fateh
Kurdistan, Kalar, 46021, Iraq
NCT Number: NCT05897606
The study was performed on 160 participants, to ensure the impact of multi vitamin and mineral to reduce NAFLD
Looking for future studies?
Notify Me22 year–78 year
All sexes
Interventional
Phase 1
Kurdistan, Kalar, 46021, Iraq
This study was performed on 160 participants, to ensure the impact of multi vitamin and mineral to reduce NAFLD.
Participants were randomly selected to participate in the study. Then divided into the groups (intervention and placebo). Intervention received supplementation for 12 weeks and placebo received same capsule was made for placebo groups.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention group received one capsule of multivitamin and minerals supplements every day, one hour after breakfast, for 12 weeks.
Placebo
Time frame: 12 weeks
Multivitamin and minerals supplement was given for 12 weeks and has role in reduce Serum Bilirubin, alkaline phosphatase (ALP), alanine transaminase (ALT), and liver enzyme was measured by blood sampling tests.
Sulaimani Polytechnic University
Other
Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With Non-alcoholic Fatty Disease (NAFLD); RCR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05268042
Body Weight, Digestive System Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT04785937
Digestive System Diseases, Fatty Liver
Reggio Emilia, RE, Italy
View Trial DetailsNCT00230087
Diabetes Mellitus, Digestive System Diseases
Seattle, Washington, United States
View Trial DetailsNCT00230113
Digestive System Diseases, Fatty Liver
Seattle, Washington, United States
View Trial Details